Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41
- 30 March 2005
- Vol. 23 (30), 3937-3945
- https://doi.org/10.1016/j.vaccine.2005.03.003
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosisMedical Microbiology and Immunology, 2004
- Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-142 malaria vaccineMolecular and Biochemical Parasitology, 2003
- Virulence, Immunogenicity, and Protective Efficacy of Two RecombinantMycobacterium bovisBacillus Calmette-Guérin Strains Expressing the Antigen ESAT-6 fromMycobacterium tuberculosisInfection and Immunity, 2003
- Manipulation of immune responses to Mycobacterium bovis by vaccination with IL‐2‐ and IL‐18‐secreting recombinant bacillus Calmette GuerinImmunology & Cell Biology, 2002
- Vaccination of Guinea Pigs with DNA Encoding the Mycobacterial Antigen MPB83 Influences Pulmonary Pathology but Not Hematogenous Spread following Aerogenic Infection withMycobacterium bovisInfection and Immunity, 2002
- Koch's Dilemma RevisitedScandinavian Journal of Infectious Diseases, 2001
- DNA vaccines against tuberculosisImmunology & Cell Biology, 1997
- Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected UgandansThe Lancet, 1994
- The global tuberculosis situation and the new control strategy of the World Health OrganizationTubercle, 1991
- Importance of thymus-derived lymphocytes in cell-mediated immunity to infectionCellular Immunology, 1973